The replacement of the replacement in menopause: Hormone therapy, controversies, truth and risk

Nursing Inquiry

Volumn 16, Issue 3, 2009, Pages 212-222

  Burrell, Beverley A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bio identical; Foucault; Hormones; Menopause; Risk

Indexed keywords

ADULT; AGED; ARTICLE; EVIDENCE BASED MEDICINE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTERPERSONAL COMMUNICATION; MENOPAUSE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TRUTH DISCLOSURE;

EID: 68949119547     PISSN: 13207881     EISSN: 14401800     Source Type: Journal    
DOI: 10.1111/j.1440-1800.2009.00456.x     Document Type: Article

References (67)

1. AACE Menopause Guidelines Revision Task Force. 2006. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of Menopause. http://www.aace.com/pub/pdf/guidelines/ menopause.pdf (accessed 8 June 2009).
2. ACOG Committee on Gynecologic Practice. 2005. ACOG Committee Opinion #322: Compounded bio-identical hormones. Obstetrics & Gynecology 106 (5 Pt 1 1139 40.
3. Anonymous. 1975. Dangers in eternal youth. The Lancet 306 (7945 1135.
4. Anonymous. 1977. Hormone replacement therapy and endometrial cancer. The Lancet 309 (8011 577 8.
5. Anonymous. 1979. Oestrogen therapy and endometrial cancer. The Lancet 313 (8126 1121 2.
6. Anonymous. 2003. Postmenopausal hormones. Hormone therapy: What happened? Our assumptions about taking hormones after menopause have mostly been dashed. How did we get it so wrong? Harvard Women's Health Watch 11 (3 2 4.
7. Australian Competition and Consumer Commission. 2006. Menopause Institute admits deceiving patients about menopause treatments. Release # MR 316/06, 20 Dec, Canberra : Australian Competition and Consumer Commission.
8. Australian Drug Evaluation Committee. 2004. ADEC Summary statement on HRT. Therapeutic Goods Administration, Department of Health and Ageing, Australian Government, 2006. http://www.tga.gov.au/docs/html/hrtadec3.htm (accessed 7 December 2007).
9. Barbo D. 1998. Menopause. In Textbook of women's health, eds L Wallis, A Kasper G Reader, 721 30. Philadelphia, PA : Lippincott-Raven.
10. Bell S. 1987. Changing ideas: The medicalisation of menopause. Social Science & Medicine 24 (6 535 42.
11. Bell S. 1995. Gendered medical science: Producing a drug for women. Feminist Studies 21 (3 469 500.
12. Boothby LA, P Doering S Kipersztok. 2004. Bio-identical hormone therapy: A review. Menopause 11 (3 356 67.
13. Canguilhem G. 1978. On the normal and the pathological. Translated by CR Fawcett. Dordrecht : Reidel.
14. Cirigliano M. 2007. Bio-identical hormone therapy: A review of the evidence. Journal of Women's Health 16 (5 600 31.
15. Coney S. 1991. The menopause industry. Auckland : Penguin Books.
16. Council of the Medical Women's Federation. 1933. An investigation of the menopause in one thousand women. The Lancet Jan : 106 8.
17. Curb D, A McTiernan SR Heckbert. 2003. Outcomes ascertainment and adjudication methods in Women's Health Initiative. Annuals of Epidemiology 13 (9S S122 8.
18. Curcio J, DA Wollner, JW Schmidt LS Kim. 2006. Is bio-identical hormone replacement therapy safer than traditional hormone replacement therapy? A critical appraisal of cardiovascular risks in menopausal women. Treatments in Endocrinology 5 (6 367 74.
19. Dennerstein L. 1996. Well-being, symptoms and the menopausal transition. Maturitas 23 (2 147 57.
20. Ettinger B. 1998. Overview of estrogen replacement therapy: A historical perspective. Proceedings of the Society for Experimental Biology & Medicine 217 (1 2 5.
21. Foucault M. 1963/1973. The birth of the clinic. Translated by A. Sheridan. London : Tavistock Publications Ltd.
22. Foucault M. 1971/1984. Nietzsche, genealogy, history. In The Foucault reader, ed. P Rabinow, 76 100. New York : Pantheon Books.
23. Foucault M. 1972/1980. Truth and power. In Power/knowledge: Selected interviews and other writings 1972-77, trans. C Gordon, L Marshall, J Mepham and K Soper, ed. C Gordon, 109 33. Brighton : Harvester Press.
24. Foucault Michel. 1998. The will to knowledge. Amended reprint edn, vol. 1, The history of sexuality. Translated by R. Hurley. London : Penguin Books.
25. Fugh-Berman A J Bythrow. 2007. Bio-identical hormones for menopausal hormone therapy: Variation on a theme. Journal of General Internal Medicine 22 (7 1030 4.
26. Grady D, S Rubin, D Petitti, C Fox, D Black, B Ettinger, V Ernester S Cummings. 1992. Hormone therapy to prevent disease and prolong life in post-menopausal women. Annals of Internal Medicine 117 (12 1016 37.
27. Greer G. 1991. The change: Women, ageing and the menopause. London : Hamish Hamilton.
28. Hope J. 2007. One million women 'have needlessly abandoned HRT'. The Daily Mail, 9 Oct.
29. Hulley S, D Grady, T Bush, C Furberg, D Herrington, B Riggs E Vittinghoff. 1998. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Journal of American Medical Association 280 : 605 13.
30. Investigators, Writing Group for the Women's Health Initiative. 2002. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomised controlled trial. Journal of American Medical Association 288 : 321 33.
31. Kendall G G Wickham. 1990. Using Foucault's methods: Introducing qualitative methods. London : Sage Publications.
32. Kennedy D, C Baum MB Forbes. 1985. Noncontraceptive estrogens and progestins: Use patterns over time. Obstetrics & Gynecology 65 (3 441 6.
33. Krieger N, I Lowy, R Aronowitz, J Bigby, K Dickersin, E Garner, JP Gaudilliere et al. 2005. Hormone replacement therapy, cancer, controversies, and women's health: Historical, epidemiological, biological, clinical, and advocacy perspectives. Journal of Epidemiology & Community Health 59 (9 740 8.
34. Langer RD, E White, CE Lewis, JM Kotchen, SL Hendrix M Trevisan. 2003. The Women's Health Initiative observational study: Baseline characteristics of participants and reliability of baseline measures. Annuals of Epidemiology 13 (9S S107 21.
35. Lawlor DA, G Davey Smith S Ebrahim. 2004. The hormone replacement-coronary heart disease conundrum: Is this the death of observational epidemiology? International Journal of Epidemiology 33 : 464 7.
36. Lee J, D Zava V Hopkins. 2002. What your doctor may not tell you about breast cancer! How hormone balance can help save your life. New York : Warner Books.
37. Lyons AC C Griffin. 2003. Managing menopause: A qualitative analysis of self help literature for women at midlife. Social Science and Medicine 56 (8 1629 42.
38. Marder MZ, U Joshi ID Mandel. 1979. Estrogen concentration in human parotid and submaxillary saliva. Journal of Dental Research 58 : 2370.
39. McCrea FB. 1983. The politics of menopause - The discovery of a deficiency disease. Social Problems 31 (1 111 23.
40. Menopause Institute of Australia. 2006. Natural hormone therapy programme. Sydney : The Menopause Institute of Australia Pty Ltd.
41. Million Women Study Collaborators. 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. The Lancet 362 (9382 419 27.
42. National Cancer Institute. 2007. Menopausal hormone replacement therapy use and cancer: Questions and answers : National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/Risk/menopausal-hormones (accessed 10 May 2007).
43. National Health Service. 2007. Menopause: Patient information leaflet. National Health Service, Crown Print. http://cks.library.nhs.uk/patient- information-leaflet/menopause (accessed 4 December 2007).
44. National Institutes of Health. 2005. Facts about menopausal hormone therapy. US Department of Health and Human Services. http://www.nhlbi.nih.gov/ health/women/pht-facts.pdf (accessed 4 December 2007).
45. Neugarten B R Kraines. 1965. 'Menopause symptoms' in women of various ages. Psychosomatic Medicine xxvii (3 266 73.
46. New Zealand Guidelines Group. 2007. Hormone replacement therapy 2004. http://www.nzgg.org.nz/guidelines/0078/HRT-summary-web.pdf (accessed 4 December 2007).
47. th edn. Cleveland, OH : North American Menopause Society.
48. Palmlund I. 2006. Loyalties in clinical research on drugs: The case of hormone replacement therapy. Social Science & Medicine 63 (2 540 51.
49. Petitti Diana B. 2002. Hormone replacement therapy for prevention. More evidence, more pessimism. Journal of American Medical Association 288 : 99 101.
50. Petitti Diana B David A Freedman. 2005. Invited commentary: How far can epidemiologists get with statistical adjustment? American Journal of Epidemiology 162 (5 415 18.
51. Prentice Ross L, Robert Langer, Garnet Anderson David Barad. 2005a. Response to 'How far can epidemiologists get with statistical adjustment?'. American Journal of Epidemiology 162 (5 419 20.
52. Prentice Ross L, Robert Langer, Marcia L Stefanick, Barbara V Howard, Mary Pettinger, Garnet Anderson, David Barad et al. 2005b. Combined postmenopausal hormone therapy and cardiovascular disease: Toward resolving the discrepancy between observational studies and the Women's Health Initiative Clinical Trial. American Journal of Epidemiology 162 (5 404 14.
53. Prentice Ross L, Robert D Langer, Marcia L Stefanick, Barbara V Howard, Mary Pettinger, Garnet L Anderson, David Barad et al. 2006. Combined analysis of Women's Health Initiative Observational and Clinical Trial data on postmenopausal hormone treatment and cardiovascular disease. American Journal of Epidemiology 163 (7 589 99.
54. Price SL, S Storey M Lake. 2008. Menopause experiences of women in rural areas. Journal of Advanced Nursing 61 (5 503 11.
55. Seaman B G Seaman. 1978. Women and the crisis in sex hormones: An investigation of the dangerous uses of hormones from birth control to menopause, and the safe alternatives. Hassocks, Sussex : Harvester Press.
56. Shapiro S. 2007. Recent epidemiological evidence relevant to the clinical management of the menopause. Climacteric 10 : 2 15.
57. Shildrick Margrit. 1997. Leaky bodies and boundaries: Feminism, postmodernism and (bio) ethics. London : Routledge.
58. Shoham Zeev Gideon Kopernik. 2004. Tools for making correct decisions regarding hormone therapy. Part I. Background and drugs. Fertility & Sterility 81 (6 1447 57. (Pubitemid 38748982)
59. Stefanick Marcia L. 2005. Estrogens and progestins: Background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. American Journal of Medicine 118 (12 Suppl. 2 64 73.
60. Sturdee D, T Wade-Evans, M Paterson, M Thom J Studd. 1978. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women. British Medical Journal 1 : 1575 7.
61. Tanenbaum L. 2002. The bitter pill: Bombarded by propaganda on premarin, we can't trust our doctors and we can't trust ourselves. In Women and health: power, technology, inequality, and conflict in a gendered world, ed. KS Ratcliff, 167 70. Boston : Allyn & Bacon.
62. Topo P. 1997. Climacteric hormone therapy in medical and lay texts in Finland from 1955 to 1992. Social Science & Medicine 45 (5 751 60.
63. Turner Bryan. 1997. Foreword: From governmentality to risk, some reflections on Foucault's contribution to medical sociology. In Foucault; health and medicine, eds Alan Petersen Robin Bunton, ix xii. London : Routledge.
64. Turner BS. 1996. The body and society: Explorations in social theory. 2nd edn. London : Sage.
65. Utian W H. 1997. Menopause: A modern perspective from a controversial history. Maturitas 26 (2 73 82.
66. Wilson R. 1966. Feminine forever. London : WH Allen.
67. Women's Health Action. 2004. Hormone replacement therapy: New information for women. New Zealand Guidelines Group, 25 Jan 2007. http://www.nzgg.org.nz/ index.cfm?fuseaction=download&fusesubaction=template&libraryID=219 (accessed 4 December 2007).